Benedict Law
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Supramolecular Self-Assembly in Materials
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Advanced biosensing and bioanalysis techniques 13
- RNA Interference and Gene Delivery 12
- Biomaterials 14
- Supramolecular Self-Assembly in Materials 8
- Nanoparticle-Based Drug Delivery 5
- Co-authors
- Ching‐Hsuan Tung (13 shared papers)Ralph Weissleder (7 shared papers)Steven Y. Qian (8 shared papers)Anil Wagh (10 shared papers)Jagdish Singh (2 shared papers)Buddhadev Layek (1 shared paper)Gitanjali Sharma (1 shared paper)Luisa Quinti (1 shared paper)
- Journals
- Bioconjugate Chemistry (4 papers)Free Radical Biology and Medicine (3 papers)Biomacromolecules (3 papers)Analytical Biochemistry (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- United StatesSouth KoreaThailand
In The Last Decade
Benedict Law
41 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 100
- Biomaterials 395
- Molecular Biology 720
- Pharmaceutical Science 58
- Cancer Research 130
- Biomedical Engineering 359
Countries citing papers authored by Benedict Law
This map shows the geographic impact of Benedict Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benedict Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benedict Law more than expected).
Fields of papers citing papers by Benedict Law
This network shows the impact of papers produced by Benedict Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benedict Law. The network helps show where Benedict Law may publish in the future.
Co-authors
The 25 scholars most cited alongside Benedict Law, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 144 | |
| 2 | 2013 | 136 | |
| 3 | 2006 | 105 | |
| 4 | 2009 | 100 | |
| 5 | 2012 | 95 | |
| 6 | 2016 | 69 | |
| 7 | 2004 | 69 | |
| 8 | 2006 | 66 | |
| 9 | 2013 | 61 | |
| 10 | 2009 | 57 | |
| 11 | 2009 | 55 | |
| 12 | 2007 | 43 | |
| 13 | 2017 | 41 | |
| 14 | 2018 | 35 | |
| 15 | 2012 | 28 | |
| 16 | 2019 | 27 | |
| 17 | 2006 | 26 | |
| 18 | 2011 | 25 | |
| 19 | 2012 | 24 | |
| 20 | 2018 | 21 |
About Benedict Law
Benedict Law is a scholar working on Molecular Biology, Biomaterials, Oncology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (13 papers), RNA Interference and Gene Delivery (12 papers), Supramolecular Self-Assembly in Materials (8 papers), Protease and Inhibitor Mechanisms (6 papers), Nanoplatforms for cancer theranostics (5 papers), Nanoparticle-Based Drug Delivery (5 papers), Peptidase Inhibition and Analysis (5 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Biomaterials (395 citations), Molecular Biology (720 citations), Pharmaceutical Science (58 citations), Cancer Research (130 citations) and Biomedical Engineering (359 citations). Benedict Law has collaborated with scholars based in United States, South Korea and Thailand. Frequent co-authors include Ching‐Hsuan Tung, Ralph Weissleder, Steven Y. Qian, Anil Wagh, Jagdish Singh, Buddhadev Layek, Gitanjali Sharma, Luisa Quinti, Chengwen Sun and Yongdoo Choi. Their work appears in journals such as Bioconjugate Chemistry, Free Radical Biology and Medicine, Biomacromolecules, Analytical Biochemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.